These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15944842)

  • 1. Regression of microalbuminuria in type 1 diabetic patients: results of a sequential intervention with improved metabolic control and ACE inhibitors.
    Vilarrasa N; Soler J; Montanya E
    Acta Diabetol; 2005 Jun; 42(2):87-94. PubMed ID: 15944842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group.
    Lancet; 1997 Jun; 349(9068):1787-92. PubMed ID: 9269212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study. The Microalbuminuria Collaborative Study Group.
    Diabet Med; 1999 Nov; 16(11):918-25. PubMed ID: 10588521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term reduction of microalbuminuria after 1 year of angiotensin converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients.
    Brichard SM; Santoni JP; Thomas JR; van de Voorde K; Ketelslegers JM; Lambert AE
    Diabete Metab; 1990; 16(1):30-6. PubMed ID: 2185055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
    Ahmad J; Siddiqui MA; Ahmad H
    Diabetes Care; 1997 Oct; 20(10):1576-81. PubMed ID: 9314638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing diabetic nephropathy: an audit.
    Hansen HP; Lund SS; Rossing P; Tarnow L; Nielsen FS; Jensen T; Parving HH
    Scand J Clin Lab Invest; 2001; 61(6):471-7. PubMed ID: 11681537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM.
    Penno G; Chaturvedi N; Talmud PJ; Cotroneo P; Manto A; Nannipieri M; Luong LA; Fuller JH
    Diabetes; 1998 Sep; 47(9):1507-11. PubMed ID: 9726242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic control and prognosis in type I diabetic patients with microalbuminuria.
    Bojestig M; Arnqvist HJ; Karlberg BE; Ludvigsson J
    Diabetes Care; 1996 Apr; 19(4):313-7. PubMed ID: 8729152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
    Crepaldi G; Carta Q; Deferrari G; Mangili R; Navalesi R; Santeusanio F; Spalluto A; Vanasia A; Villa GM; Nosadini R
    Diabetes Care; 1998 Jan; 21(1):104-10. PubMed ID: 9538979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of glomerulopathy predicts long-term urinary albumin excretion rate in patients with type 1 diabetes and microalbuminuria.
    Bangstad HJ; Osterby R; Hartmann A; Berg TJ; Hanssen KF
    Diabetes Care; 1999 Feb; 22(2):314-9. PubMed ID: 10333951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial.
    O'Hare P; Bilbous R; Mitchell T; O' Callaghan CJ; Viberti GC;
    Diabetes Care; 2000 Dec; 23(12):1823-9. PubMed ID: 11128360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
    Laffel LM; McGill JB; Gans DJ
    Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors and probucol suppress the time-dependent increase in urinary Type IV collagen excretion of Type II diabetes mellitus patients with early diabetic nephropathy.
    Nishimura M; Sasaki T; Ohishi A; Oishi M; Kono S; Totani Y; Kato Y; Noto Y; Misaki S; Higashi K; Shimada F; Wakasugi H; Inoue K; Hoshiyama Y; Yamada K
    Clin Nephrol; 2001 Aug; 56(2):96-103. PubMed ID: 11522101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microalbuminuria and diabetic nephropathy. Detection and correlation with other degenerative complications].
    Thivolet C; Ayzac L; Simonet C; Rebattu B; Bernard P; Tourniaire J
    Presse Med; 1990 Jun; 19(23):1075-80. PubMed ID: 2141408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
    Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term prevention of diabetic nephropathy: an audit.
    Schjoedt KJ; Hansen HP; Tarnow L; Rossing P; Parving HH
    Diabetologia; 2008 Jun; 51(6):956-61. PubMed ID: 18385971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term follow-up study of childhood onset type-1 diabetic patients.
    Dahlquist G; Stattin EL; Rudberg S
    Nephrol Dial Transplant; 2001 Jul; 16(7):1382-6. PubMed ID: 11427629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data.
    ACE Inhibitors in Diabetic Nephropathy Trialist Group
    Ann Intern Med; 2001 Mar; 134(5):370-9. PubMed ID: 11242497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive diabetes management decreases Na-Li countertransport in young subjects with type 1 diabetes and enlarged kidneys.
    Lawson ML; Sochett EB; Frank MR; Fry MK; Stephens D; Chait P; Daneman D
    J Diabetes Complications; 2000; 14(6):333-9. PubMed ID: 11120458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.